For research use only. Not for therapeutic Use.
CDK9-IN-10(CAT: I016340) is a potent and selective small-molecule inhibitor of cyclin-dependent kinase 9 (CDK9), a key regulator of transcriptional elongation through phosphorylation of RNA polymerase II. By blocking CDK9 activity, this compound disrupts transcriptional control of oncogenes and survival pathways, making it a valuable tool for cancer research and therapeutic development. CDK9-IN-10 has shown strong inhibitory activity in cellular models, offering utility in studying transcriptional regulation, apoptosis, and tumor progression. It is widely applied in oncology, epigenetics, and transcription biology to probe CDK9-dependent signaling and evaluate strategies targeting transcriptional addiction in cancer.
CAS Number | 3542-63-0 |
Synonyms | 5,8-dihydroxy-2-phenyl-7-phenylmethoxychromen-4-one |
Molecular Formula | C22H16O5 |
Purity | ≥95% |
IUPAC Name | 5,8-dihydroxy-2-phenyl-7-phenylmethoxychromen-4-one |
InChI | InChI=1S/C22H16O5/c23-16-11-18(15-9-5-2-6-10-15)27-22-20(16)17(24)12-19(21(22)25)26-13-14-7-3-1-4-8-14/h1-12,24-25H,13H2 |
InChIKey | OQHAZMRRNANBMN-UHFFFAOYSA-N |
SMILES | C1=CC=C(C=C1)COC2=C(C3=C(C(=C2)O)C(=O)C=C(O3)C4=CC=CC=C4)O |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |